CEFUROXIME AXETIL | N050605 | GLAXOSMITHKLINE
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizens Petition from The Weinberg Group Inc. FDA-2002-P-0007 · 12 docket documents The Weinberg Group Inc. filed this citizen petition under 21 CFR 10.20 and 10.30 and Section 505(b)(2)(c) of the Federal Food, Drug and Cosmetic Act requesting that the FDA declare Cefuroxime Axetil Tablets for Oral Suspension in 125 mg and 250 mg strengths suitable for submission as an ANDA, with t | Other | 2011-01-14 | Denied | The Weinberg Group Inc. |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.